Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Clinical trial authorization granted in U.K. for phase I study of FOR-6219

July 5, 2018

JCR initiates phase III trial of JR-401X for SHOX deficiency

July 4, 2018

Merck & Co. presents FFA1 receptor agonists

July 3, 2018

NovaTarg divulges new AMPK activators for diabetes

July 3, 2018

FDA grants fast track designation to CUTX-101 for treatment of classic Menkes disease

July 3, 2018

Cell therapies wake up and smell the coffee

July 3, 2018

JCR initiates phase II study of JR-141 as treatment of Hunter syndrome in Brazil

July 2, 2018

Patient enrollment ongoing in phase I/II study of SOBI-003 in pediatric MPS IIIA

July 2, 2018

Positive CHMP opinion granted for Mepsevii for the treatment of mucopolysaccharidosis VII

July 2, 2018

FDA grants approval for Qbrexza cloth as treatment of primary axillary hyperhidrosis

July 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...